For the Inventor, By the Inventor

Enter assignee name

Buffalo, NY, United States of America

Athenex, Inc.

USPTO Granted Patents = 13

CIPO Patents = 1

EPO Patents = 5

Trademarks = 7

Forward Citations = 25

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

David G Hangauer, Jr (11 out of 32 patents)

Michael P Smolinski (5 out of 10 patents)

Sameer Urgaonkar (3 out of 4 patents)

4. Johnson Yiu-Nam Lau (2 out of 29 patents)

5. Nader N Nasief Abdel-Sayed (2 out of 2 patents)

6. James Lindsay Clements (2 out of 2 patents)

7. Debasis Patra (2 out of 8 patents)

8. Jeremy A Cody (2 out of 8 patents)

9. Jonathon Salsbury (2 out of 7 patents)

10. Grant Jackson Palmer (2 out of 18 patents)

11. Paul Kenneth Isbester (2 out of 8 patents)

12. Min-Fun Rudolf Kwan (1 out of 6 patents)

13. E Douglas Kramer (1 out of 5 patents)

14. David Lawrence Cutler (1 out of 5 patents)

15. Jane Fang (1 out of 2 patents)

13 patents: Sort by Forward Citations

1. 11739089 - Acetamido-phenyltetrazole derivatives and methods of using the same (2023-08-29),

2. 10973828 - Biaryl compositions and methods for modulating a kinase cascade (2021-04-13),

3. 10899747 - Biaryl piperidine amide compounds and methods of use thereof (2021-01-26),

4. 10617693 - Methods of treating and/or preventing actinic keratosis (2020-04-14),

5. 10450303 - Biaryl piperidine amide compounds and methods of use thereof (2019-10-22),

6. 10323001 - Compositions for modulating a kinase cascade and methods of use thereof (2019-06-18),

7. 10213435 - Biaryl compositions and methods for modulating a kinase cascade (2019-02-26),

8. 10196357 - Biaryl compositions and methods for modulating a kinase cascade (2019-02-05),

9. 10106505 - Composition and methods for modulating a kinase cascade (2018-10-23),

10. 9926273 - Composition and methods for modulating a kinase cascade (2018-03-27),

11. 9655903 - Compositions and methods of treating cell proliferation disorders (2017-05-23),

12. 9580387 - Biaryl compositions and methods for modulating a kinase cascade (2017-02-28),

13. 9556120 - Compositions for modulating a kinase cascade and methods of use thereof (2017-01-31),

Athenex, Inc. is a global biopharmaceutical company dedicated to the development and commercialization of innovative therapies for the treatment of cancer. With a focus on both oral and injectable oncology drugs, Athenex aims to improve outcomes and quality of life for cancer patients worldwide. Through its proprietary technology platforms, the company develops novel therapies that target multiple pathways to overcome cancer drug resistance and enhance therapeutic efficacy. Athenex is committed to advancing the future of cancer care through its strong pipeline and commitment to scientific innovation.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#28 in Buffalo, NY

#1,281 in New York

#23,150 in US

#43,682 in the World

Buffalo, NY, United States of America

Athenex, Inc.

Forward Citations = 25

19 inventors:

David G Hangauer, Jr (11 out of 32 patents)

Michael P Smolinski (5 out of 10 patents)

Sameer Urgaonkar (3 out of 4 patents)

4. Johnson Yiu-Nam Lau (2 out of 29 patents)

5. Nader N Nasief Abdel-Sayed (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…